Haaglanden Medisch Centrum Stichting — Clinical Trial Site

59 Registered trials

30 Currently recruiting

Organisation

Haaglanden Medisch Centrum Stichting

Location

Leidschendam, Netherlands

Identifier

ORG-100029478

Address

Lijnbaan 32, 2512 VA, Netherlands

Departments

Afdeling Longoncologie
Cardiology
Clinical Oncology
Department of Neurology/Neuro-Oncology
Department of Surgery
Emergency Department
Gynecology and obstetrics
Hematology
Intensive Care
Internal medicine
Internal Oncology
interne geneeskunde
Interne oncologie
Longgeneeskunde
Lung
Medical Oncology
Medische Oncologie
N/A
Neurology
Neurosurgery
Oncologie
Oncology
Pediatrics
Pulmonary Science
Pulmonology
Radiation Oncology
Reproductive medicine and gynecology
Sports Medicine
Surgery
Trialbureau Haaglanden Medisch Centrum

Clinical trials at this site (59)

Search interface

EORTC-1537-LYMG: Very early FDG-PET-response adapted targeted therapy for advanced Hodgkin lymphoma: a single-arm phase II study Ended

2023-508478-27-00 Advanced stage Hodgkin Lymphoma 4 2019-07-30
Liposomal iRInotecan, Carboplatin or oXaliplatin in the first line treatment of esophagogastric cancer: a randomized phase 2 study (LyRICX) Ended

2023-509287-26-00 previously untreated metastatic or locally advanced eso 4 2019-07-01
Image‐guided de‐escalation of neoadjuvant chemotherapy in HER2‐positive breast cancer: the TRAIN‐3 study Ended

2024-516205-23-00 Breast cancer 4 2019-04-09
DORA Trial: Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC) Ended

2024-513867-19-00 metastatic Castration-Resistant Prostate Cancer (mCRPC) 5 2019-01-31
Endocrine therapy plus CDK 4/6 inhibition in first- or second-line for hormone receptor positive advanced breast cancer - the SONIA study Ended

2024-516204-42-00 Breast cancer 5 2017-11-21
A Phase III double-blind placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients Ended

2022-502324-48-00 Patients with resected colon carcinoma 5 2014-08-05
Biomarker discovery randomized phase IIb trial with carboplatin-cyclophosphamide versus paclitaxel with or without atezolizumaB as first-lin… Ended

2024-516202-39-00 Metastatic breast cancer 4 2013-10-10
A randomized, open-label, multicentric, two-arm pivotal trial of SonoCloud-9 combined with carboplatin (CBDCA) vs standard of care lomustine… Halted

2023-505829-14-00 First recurrence glioblastoma 5 2023-12-22
A Randomized, Double-Blind, Placebo-Controlled, Parallel, 4-Arm Dose Ranging Study of the Safety and Efficacy of Nalbuphine Extended-Release… Ended

2023-505296-72-00 Idiopathic Pulmonary Fibrosis (IPF) 4 2023-12-12
A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cel… Ended

2022-502480-38-00 Non−small cell lung cancer (NSCLC) 5 2020-09-09
Phase 3 Study of Pembrolizumab plus Enzalutamide in mCRPC Ended

2022-500785-10-00 Metastatic Castration-Resistant Prostate Cancer 5 2019-08-23